Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma Group (MREO) Return on Capital Employed: 2024-2025

Historic Return on Capital Employed for Mereo BioPharma Group (MREO) over the last 2 years, with Sep 2025 value amounting to -0.90%.

  • Mereo BioPharma Group's Return on Capital Employed fell 40.00% to -0.90% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.90%, marking a year-over-year decrease of 40.00%. This contributed to the annual value of -0.82% for FY2024, which is 37.00% down from last year.
  • According to the latest figures from Q3 2025, Mereo BioPharma Group's Return on Capital Employed is -0.90%, which was down 12.71% from -0.80% recorded in Q2 2025.
  • In the past 5 years, Mereo BioPharma Group's Return on Capital Employed registered a high of -0.50% during Q3 2024, and its lowest value of -0.90% during Q3 2025.
  • Its 2-year average for Return on Capital Employed is -0.69%, with a median of -0.69% in 2024.
  • Data for Mereo BioPharma Group's Return on Capital Employed shows a maximum YoY tumbled of 40bps (in 2025) over the last 5 years.
  • Mereo BioPharma Group's Return on Capital Employed (Quarterly) stood at -0.69% in 2024, then slumped by 40bps to -0.90% in 2025.
  • Its last three reported values are -0.90% in Q3 2025, -0.80% for Q2 2025, and -0.75% during Q1 2025.